Measles-Mumps-Rubella Vaccine
"Measles-Mumps-Rubella Vaccine" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A combined vaccine used to prevent MEASLES; MUMPS; and RUBELLA.
| Descriptor ID |
D022542
|
| MeSH Number(s) |
D20.215.894.815.500 D20.215.894.899.404.500 D20.215.894.899.488.500 D20.215.894.899.779.500
|
| Concept/Terms |
Measles-Mumps-Rubella Vaccine- Measles-Mumps-Rubella Vaccine
- Measles Mumps Rubella Vaccine
- Vaccine, Measles-Mumps-Rubella
- Measles, Mumps, Rubella Vaccine
- MMR Vaccine
- Vaccine, MMR
- Mumps-Measles-Rubella Vaccine
- Mumps Measles Rubella Vaccine
- Vaccine, Mumps-Measles-Rubella
|
Below are MeSH descriptors whose meaning is more general than "Measles-Mumps-Rubella Vaccine".
Below are MeSH descriptors whose meaning is more specific than "Measles-Mumps-Rubella Vaccine".
This graph shows the total number of publications written about "Measles-Mumps-Rubella Vaccine" by people in this website by year, and whether "Measles-Mumps-Rubella Vaccine" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 2004 | 0 | 1 | 1 |
| 2011 | 1 | 0 | 1 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 0 | 1 |
| 2019 | 3 | 0 | 3 |
| 2020 | 2 | 0 | 2 |
| 2023 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Measles-Mumps-Rubella Vaccine" by people in Profiles.
-
Management and Control Issues Related to Two Mumps Outbreaks in Houston: Future Implications. Clin Infect Dis. 2023 02 08; 76(3):e1416-e1420.
-
Immunogenicity and Safety of a Measles-Mumps-Rubella Vaccine Administered as a First Dose to Children Aged 12 to 15 Months: A Phase III, Randomized, Noninferiority, Lot-to-Lot Consistency Study. J Pediatric Infect Dis Soc. 2020 Apr 30; 9(2):194-201.
-
Combating vaccine hesitancy and other 21st century social determinants in the global fight against measles. Curr Opin Virol. 2020 04; 41:1-7.
-
Measles virus infection diminishes preexisting antibodies that offer protection from other pathogens. Science. 2019 11 01; 366(6465):599-606.
-
Preventing Measles in Immunosuppressed Cancer and Hematopoietic Cell Transplantation Patients: A Position Statement by the American Society for Transplantation and Cellular Therapy. Biol Blood Marrow Transplant. 2019 11; 25(11):e321-e330.
-
Measles, mumps, rubella (vaccine) and varicella vaccines in pediatric liver transplant: An initial analysis of post-transplant immunity. Pediatr Transplant. 2019 08; 23(5):e13490.
-
The physician-scientist: defending vaccines and combating antiscience. J Clin Invest. 2019 04 29; 129(6):2169-2171.
-
Public Health and Economic Consequences of Vaccine Hesitancy for Measles in the United States. JAMA Pediatr. 2017 09 01; 171(9):887-892.
-
Parental report of vaccine receipt in children with autism spectrum disorder: Do rates differ by pattern of ASD onset? Vaccine. 2016 Mar 08; 34(11):1335-42.
-
Measles and mumps outbreaks in the United States: Think globally, vaccinate locally. Vaccine. 2014 Aug 20; 32(37):4703-4.